Characterization of recombinant human brain-derived neurotrophic factor variants

Area of Science:

• Biochemistry
• Molecular Biology
• Protein Chemistry

Background:

• Recombinant human brain-derived neurotrophic factor (rHu-BDNF) is crucial for neuronal survival and differentiation.
• Understanding post-translational modifications and variants of rHu-BDNF is essential for its therapeutic applications.
• Expression in Escherichia coli can lead to various protein variants requiring characterization.

Purpose of the Study:

• To perform chemical characterization of rHu-BDNF variants produced in E. coli.
• To assess the in vitro biological activity of these rHu-BDNF variants.
• To investigate the structural integrity and functional relevance of identified variants.

Main Methods:

• Peptide mapping using Glu-C protease and cyanogen bromide digestion.
• Analysis of digested peptides via mass spectrometry and Edman sequencing.
• High-temperature reversed-phase liquid chromatography (RPLC) for variant separation and identification.

Main Results:

• Identified variants with methionine sulfoxide at positions 31 and 61 (Peaks 1 and 2).
• Characterized Peak 4 variants containing norleucine or methionine sulfoxide at positions 61 and 92.
• Observed norleucine substitution for methionine at position 31 in Peak 5.
• All variants demonstrated in vitro biological activity comparable to the BDNF standard.

Conclusions:

• The chemical modifications in the identified rHu-BDNF variants do not abolish their biological activity.
• The trkB receptor-ligand binding domain appears to be preserved across these variants.
• These findings support the potential use of these characterized rHu-BDNF variants in therapeutic contexts.